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Angucyclinone antibioticsAbstract A stereoselective chiral Lewis acid promoted reaction of siloxydiene (±)-13 and dieno-
phile complex 18, gave a 4:1 mixture of urdamycinone B (1) and its C-3 epimer (24) in several steps
in 12% overall yield. Separation of these products was achieved by high performance liquid chro-
matography (HPLC).
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The angucycline antibiotics are secondary metabolites pro-
duced by micro-organisms which are found in various soil
samples and shallow sea mud (Rohr and Thiericke, 1992;
Kharel et al., 2012). A comprehensive review on the isolation,
structure and biological properties of these antibiotics was
published by Rohr and Thiericke (1992). Diels–Alder routes
to angucyclines/angucyclinones antibiotic and their analogues
have been very successful. The groups of Bowie (Rozek et al.,
1998), Larsen (Caygill et al., 1997, 2001; Larsen et al., 1996;
Larsen and O’Shea, 1993a, 1993b, 1995, 1996), Collet (Collet
et al., 2004), Carren˜o (Carren˜o et al., 1999, 2000), Krohn53 3262; fax: +60 4 657 4854.
. Osman).
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/10.1016/j.arabjc.2015.04.022(Krohn et al., 2003, 2004; Krohn and Micheel, 1998; Krohn
and Khanbabaee, 1994), Sulikowski (Boyd and Sulikowski,
1995; Kim et al., 1997), Matsuo (Matsuo et al., 1996, 1999),
have developed strategies based upon the Diels–Alder reac-
tions of naphthoquinones and ‘semicyclic’ dienes to construct
benz[a]anthraquinones.
To date, urdamycinone B has been prepared by the
Sulikowski (Boyd and Sulikowski, 1995; Kim et al., 1997)
and Matsuo (Matsuo et al., 1996, 1999) groups using this type
of approach. Their methodologies resulted in the preparation
of 1:1 mixtures of urdamycinone B (1) and its C-3 epimer (24).ing Saud University.
ivecommons.org/licenses/by-nc-nd/4.0/).
he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
2 H. Osman et al.Previous synthetic work within the Larsen group has
resulted in the asymmetric syntheses of the angucycline antibi-
otics emycin A (3) (Larsen et al., 1996), rubiginone B1 (4) and
B2 (6) (Larsen and O’Shea, 1995), ochromycinone (5) (Larsen
et al., 1996), and tetrangomycin (7) (Landells et al., 2003). All
of these utilised an asymmetric Diels–Alder reaction of com-
plex 9 prepared from juglone 8 and a Lewis acid derived from
(S)-3,30-diphenyl-1,10-binaphthalene-2,20-diol, BH3.THF and
acetic acid (Kelly et al., 1986).Kelly et al. in the asymmetric synthesis of bostrycin,
reported that complex 9 displayed remarkable facial selectivity
in its reaction with acetoxybutadiene 10 to give 11 as the sole
cycloaddition product. From models they proposed that the
top face of the dienophile complex 9 was blocked by the ligand
of the Lewis acid and that the diene could only react from the
bottom (back) face via an endo-transition state (Scheme 1).
Larsen and O’Shea used complex 9 in reactions with dienes
such as (±)-12 for the asymmetric syntheses of (+)-3 and (+)-
5 (Larsen et al., 1996). The high stereoselectivity shown in
these Diels–Alder reactions was attributed to a double stereod-
ifferentiation process whereby only one enantiomer of the
diene was matched with complex 9. This resulted in an ‘effec-
tive’ kinetic resolution of the racemic diene.Scheme 1 Asymmetric synthesis of cycloadduct 11 from achira
Please cite this article in press as: Osman, H. et al., A stereoselective approach to t
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.022Landells and Larsen extended this methodology to their
synthesis of ()-tetrangomycin (7) (Landells et al., 2003).
The key process was the Diels–Alder reaction of complex 9
and diene (±)-13 [(±)-(E)-5-dimethylphenylsilyl-5-methyl-1-
(2-trimethylsiloxyvinyl)cyclohexene] (Scheme 2).
Once again an ‘effective’ kinetic resolution of (±)-13
occurred and cycloadducts 14a and 14b were formed with
de’s ranging from 82% to 88%. Upon aromatisation of the
mixture of cycloadducts, angucycline 15 was obtained withee’s ranging from 67% to 78%. From the result, the ee of 15
was less than the de of the cycloadduct suggested that the facial
selectivity of the dienophile complex 9 was not complete and
that reaction was occurring, to a small degree, at the more hin-
dered face. The more reactive face of the diene is that syn to the
large phenyldimethylsilyl group, which is in a pseudo-equato-
rial orientation. In this case the transition state, which leads
to 14b, was believed to be of higher energy due to steric inter-
actions of the dienophile with the pseudo-axial methyl sub-
stituent of the diene.
The aim of the current research was to extend the
methodology of Landells and Larsen (Landells et al., 2003)
who used a chiral Lewis acid to promote the reaction of
diene 13 and 5-hydroxynaphthoquinone (17) to achieve
asymmetric induction in their synthesis of tetrangomycin
(7). This research involves developing a stereoselective syn-
thesis of urdamycinone B (1) using the latter approach.
The proposed strategy will rely on the stereoselectivity of
the Diels–Alder reaction of 17 and diene (13). The ratio of
urdamycinone B (1) to its C-3 epimer will be determined
by that of the four endo-cycloadducts 19a to 19d.l diene 10 and juglone (8) via complex 9 (Kelly et al., 1986).
he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
Scheme 2 Asymmetric Diels–Alder reaction of juglone 8 and diene (±)-13 (Andrews et al., 2000).
A stereoselective approach to the angucyclinone antibiotics 32. Experimental
2.1. General
Melting points were recorded on a Gallenkamp capillary melt-
ing point apparatus or a Mettler Toledo FP62 automatic melt-
ing point apparatus and are uncorrected. 1H and 13C NMR
assignments were made on the basis of chemical shift and
the coupling information obtained from one or two-dimen-
sional experiments (e.g., COSY, HSQC, HMBC, DEPT and
NOESY). Infrared (IR) spectra were recorded on a Perkin
Elmer 1600 series FTIR spectrophotometer. Low resolution
mass spectra were run on a Shimadzu QP8000 alpha mass
detector with APCI or ESI probes using a manual Rheodyne
injector and a Shimadzu LC10AD HPLC pump to provide
direct sample injection. High resolution mass spectra were
recorded by Bruce Clark using a Kratos MSORF mass spec-
trometer. Elemental analyses were carried out using a Carlo
Erba 1108 CHNS combustion analyser. Polarimetry was per-
formed using a Jasco DIP-1000 Digital polarimeter with a cell
of 10 cm in length and 3.5 mm internal diameter and the
observed rotation was measured at 589 nm (sodium D line).
Thin-layer chromatography (TLC) was performed on Merck
silica gel (DC Alurolle Kieselgel 60 F254, 0.2 mm layer) plates
in the solvent system indicated. Organic reagents for moisture
sensitive reactions were distilled from the following drying
agents: tetrahydrofuran and ether (sodium-benzophenone
ketyl), dichloromethane and triethylamine (calcium hydride).
All moisture sensitive reactions were performed under a nitro-
gen atmosphere.
2.1.1. Synthesis of 3-(dimethylphenylsilanyl)-9-[30,40-di-O-
acetyl-20,60-dideoxy-b-D-arabino-hexopyranosyl]-8-hydroxy-3-
methyl-6-trimethylsilanyloxy-1,2,3,4,6,6a,12a,12b-
octahydrobenz[a]anthracene-7,12-dione (19a–d)
Thermally Promoted Cycloaddition: Diels–Alder Reaction of D-
olivosyl C-glycoside angucycline: A solution of siloxydiene (13)Please cite this article in press as: Osman, H. et al., A stereoselective approach to t
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.022(130 mg, 0.390 mmol) and dienophile (17) (100 mg,
0.257 mmol) in dry dichloromethane (5 mL) was stirred for
30 min at room temperature. The mixture was poured onto
water (20 mL) and extracted into dichloromethane
(2 · 40 mL). The mixture was washed thoroughly with water
(50 mL). The organic layer was separated and dried over anhy-
drous magnesium sulphate. The solvent was removed by
rotary evaporator and the residue was puriﬁed by silica gel col-
umn chromatography [hexane/dichloromethane (1:1) as elu-
ant, RF = 0.14] to afford (9:1) mixture of adduct 19a–d
(96 mg, 51%).
Tetra-O-acetyl diborate promoted cycloaddition: Siloxydiene
(13) (557 mg, 1.70 mmol) in dichloromethane (2 mL) was
added to a red complex solution of glycosyl juglone (17)
(433 mg, 1.10 mmol), and tetra-O-acetyldiborate (299 mg,
1.10 mmol) in dry dichloromethane (10 mL) at 0 C. The mix-
ture was stirred for 30 min at 0 C, poured into water
(100 mL), extracted into dichloromethane (4 · 50 mL) and
washed thoroughly with water. The organic layer was sepa-
rated and dried over anhydrous magnesium sulphate. The sol-
vent was removed and the residue was puriﬁed by silica gel
column chromatography [hexane/dichloromethane (1:1) as
eluant, RF = 0.42] to afford a mixture of 19a–d (9:1)
(716 mg, 88%) as an oil. mmax (KBr): 3411, 2954, 1748, 1711,
1636, 1428, 1243 cm1. Found: C, 65.35; H, 7.28%.
C40H52O9Si2 requires C, 65.54; H, 7.15%. dH(500 MHz,
CDCl3): inter alia 0.30, 0.28, 0.26 and 0.24 (9H total,
4 · s, OSi(CH3)3), 0.42 (3H, s, Si(CH3)2Ph), 0.46 (3H, s,
Si(CH3)2Ph), 0.85 (3H, s, 3-CH3), 1.04 (1H, td, J= 13.5,
3.5 Hz, H-2ax), 1.29 (3H, d, J= 6.0 Hz, 50-CH3), 1.57 (1H,
q, J= 11.5 Hz, H-20ax) 1.62–1.67 (1H, m, H-1 eq), 1.76 (1H,
d, J= 15.0 Hz, H-4ax), 1.96 (1H, ddd, J= 13.5, 4.0, 3.0 Hz,
H-2 eq), 2.01 (3H, s, OAc), 2.08 (3H, s, OAc), 2.25–2.31
(1H, m, H-12b), 2.47–2.56 (2H, m, H-20eq, H-4 eq), 3.02
(1H, qd, J= 13.5, 3.5 Hz, H-1ax), 3.14 (1H, t, J= 5.0 Hz,
H-6a), 3.26 (1H, t, J= 5.0 Hz, H-12a), 3.65 (1H, dq,
J= 9.5, 6.5 Hz, H-50), 4.42 (1H, t, J= 4.5 Hz, H-6), 4.85
(1H, t, J= 9.0 Hz, H-40), 4.96 (1H, dd, J= 11.0, 2.0 Hz, H-he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
4 H. Osman et al.10), 5.15–5.23 (1H, m, H-30), 5.49 (1H, dt, J= 5.0, 2.5 Hz, H-
5), 7.35–7.37 (3H, m, H-200, H-400, H-600), 7.45 (1H, d,
J= 8.0 Hz, H-11), 7.56–7.61 (2H, m, H-300, H-500), 7.80 (1H,
d, J= 8.0 Hz, H-10), 12.39, 12.40, 12.49 and 12.50 (1H total,
4 · s, OH) ppm. dC(125 MHz, CDCl3): inter alia 3.48
(Si(CH3)2Ph), 2.83 (Si(CH3)2Ph), 0.60 (OSi(CH3)3), 18.07
(50-CH3), 20.95 (OAc), 21.06 (OAc), 22.94 (C3), 26.04 (C1),
28.21 (3-CH3), 36.81 (C2
0), 37.151 (C2), 39.95 (C12b), 43.81
(C4), 46.88 (C12a), 56.28 (C6a), 66.67 (C6), 70.85 (C1
0), 72.13
(C3
0), 74.37 (C50), 74.78 (C40), 116.72 (C11), 118.36 (C7a),
120.67 (C5), 127.56 (C2
00, C600), 128.76 (C400), 133.11 (C10),
133.67 (C9), 134.55 (C3
00, C500), 138.51 (C100), 138.98 (C11a),
142.40 (C4a), 157.40 (C8), 170.43 (OAc), 170.46 (OAc),
195.19 (C12), 206.22 (C7) ppm.2.1.2. Synthesis of (3R) and (3S)-3-(dimethylphenylsilanyl)-9-
[30,40-di-O-acetyl-20,60-dideoxy-b-D-arabino-hexopyranosyl]-8-
hydroxy-3-methyl-1,2,3,4,-tetrahydrobenz[a]anthracene-7,12-
dione (20a and 20b)
Thermally Promoted Cycloaddition: A 9:1 mixture of cycload-
duct 19a–d from the thermal reaction (35 mg, 0.048 mmol),
DBU (53 lL, 0.35 mmol) in dry dichloromethane (2 mL) was
stirred at room temperature for 30 min under an atmosphere
of air. The mixture was then poured into 1 M HCl (30 mL)
extracted into dichloromethane (2 · 20 mL). The organic layer
was separated and dried over anhydrous magnesium sulphate.
The solvent was removed in vacuo and the residue was puriﬁed
by silica column chromatography [dichloromethane as eluant,
RF = 0.30] to afford a 1:1 mixture of 20a and 20b (21 mg,
68%) as a yellow solid.
Tetra-O-acetyl diborate promoted cycloaddition: A 9:1 mix-
ture of cycloadduct 19a–d from tetra-O-acetyldiborate reaction
(250 mg, 0.300 mmol), DBU (378 lL, 2.50 mmol) in dry
dichloromethane (10 mL) was stirred at room temperature
for 30 min under an atmosphere of air. The mixture was then
poured into 1 MHCl (100 mL) extracted into dichloromethane
(2 · 60 mL). The organic layer was separated and dried over
anhydrous magnesium sulphate. The solvent was removed in
vacuo and the residue was puriﬁed by silica column chro-
matography [dichloromethane as eluant, RF = 0.30] to afford
a 1:1 mixture of 20a and 20b (169 mg, 77%) as a yellow solid.
LRMS-ESI (): Found m/z 639 [(M–H), 100%]. C37H40O8Si
requires m/z (639) (M–H). mmax (KBr): 3468 (OH), 2953,
1749, 1665, 1631, 1581, 1563, 1433, 1368, 1245 cm1. Found:
C, 69.10; H, 6.41%. C37H40O8Si requires C, 69.35; H,
6.29%. dH(500 MHz, CDCl3): 0.34 (3H, s, Si(CH3)2Ph), 0.35
(3H, s, Si(CH3)2Ph), 0.96 (3H, s, 3-CH3), 1.30 (3H, d,
J= 6.5 Hz, 50-CH3), 1.60 (1H, q, J= 12.0 Hz, H-20ax), 1.75
(2H, dd, J= 8.0, 5.0 Hz, H-2), 2.01 (3H, s, OAc), 2.09 (3H,
s, OAc), 2.52 (1H, d, J= 17.0 Hz, H-4), 2.62 (1H, ddd,
J= 12.5, 5.0, 2.0 Hz, H-20eq), 3.00 (1H, d, J= 17.0 Hz, H-
4), 3.25 (1H, dt, J= 19.5, 8.0 Hz, H-1), 3.40 (1H, dt,
J= 19.5, 5.0 Hz, H-1), 3.70 (1H, dq, J= 9.5, 6.0 Hz, H-50),
4.86 (1H, t, J= 9.5 Hz, H-40), 4.98 (1H, dd, J= 11.5,
2.0 Hz, H-10), 5.21 (1H, ddd, J= 12.0, 9.5, 5.0 Hz, H-30),
7.32–7.34 (3H, m, H-200, H-400, H-600), 7.41 (1H, d,
J= 8.0 Hz, H-5), 7.51–7.53 (2H, m, H-300, H-500), 7.73 (1H,
d, J= 7.5 Hz, H-11), 7.84 (1H, d, J= 8.0 Hz, H-10), 8.09
(1H, d, J= 7.5 Hz, H-6), 12.92 and 12.93 (1H total, 2 · s,
OH) ppm. dC(125 MHz, CDCl3): 6.34 (Si(CH3)2Ph), 6.26
(Si(CH3)2Ph), 18.08 (5
0-CH3), 18.27 (C3), 19.35 (3-CH3),Please cite this article in press as: Osman, H. et al., A stereoselective approach to t
Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.02220.95 (OAc), 21.06 (OAc), 24.83 (C1), 29.53 (C2), 36.92 (C2
0),
39.19 (C4), 71.11 (C1
0), 72.08 (C30), 74.48 (C50), 74.72 (C40),
115.05 (C7a), 119.25 (C11), 124.75 (C6), 127.67 (C2
00, C600),
129.15 (C4
00), 130.83 (C12a), 132.77 (C6a), 133.19 (C10), 134.13
(C11a), 134.58 (C3
00, C500), 135.20 (C9), 135.39 (C5), 136.65
(C1
00), 141.42 (C12b), 145.79 (C4a), 157.9 (C8), 170.35 (OAc),
170.41 (OAc), 184.79 (C12), 189.20 (C7) ppm.
2.1.3. Synthesis of (3R) and (3S)-3-(dimethylphenylsilanyl)-9-
[20,60-dideoxy-b-D-arabino-hexopyranosyl]-8-hydroxy-3-
methyl-1,2,3,4-tetrahydrobenz[a]anthracene-7,12-dione (21a
and 21b)
A 1:1 mixture of 20a and 20b (300 mg, 0.500 mmol) in THF
(30 mL) was added to a cooled solution of sodium methoxide
(253 mg, 4.70 mmol) at 0 C in methanol (60 mL). The mixture
was stirred at room temperature for two hours and then
washed with 1 M HCl and extracted into dichloromethane.
The organic layer was separated and dried over anhydrous
magnesium sulphate. The solvent was removed in vacuo to
afford a 1:1 mixture of 21a and 21b [methanol/dichloro-
methane (1:5) as eluant, RF = 0.38] (247 mg, 94%) as a yellow
solid. LRMS-ESI (): Found m/z 555 [(M–H), 100%].
C33H36O6Si requires m/z (555) (M–H)
. mmax (KBr): 3418
(OH), 2920, 1749, 1630, 1581, 1563, 1429, 1367, 1269,
1248 cm1. Found: C, 70.89; H, 6.51%. C33H36O6Si requires
C, 71.19; H, 6.52%. dH(500 MHz, CDCl3): 0.33 (3H, s,
Si(CH3)2Ph), 0.35 (3H, s, Si(CH3)2Ph), 0.96 (3H, s, 3-CH3),
1.41 (3H, d, J= 6.5 Hz, 50-CH3), 1.50 (1H, q, J= 11.5 Hz,
H-20ax), 1.75 (2H, dd, J= 8.0, 5.0 Hz, H-2), 2.48–2.53 (2H,
m, 4-H, H-20eq), 3.00 (1H, d, J= 17.0 Hz, H-4), 3.19–3.30
(2H, m, H-1, H-40), 3.40 (1H, dt, J= 19.0, 5.0 Hz, H-1),
3.52 (1H, dq, J= 9.0, 6.5 Hz, H-50), 3.83–3.88 (1H, m, H-
30), 4.99 (1H, dd, J= 11.3, 1.5 Hz, H-10), 7.32–7.35 (3H, m,
H-200, H-400, H-600), 7.41 (1H, d, J= 8.0 Hz, H-5), 7.51–7.55
(2H, m, H-300, H-500), 7.70 (1H, d, J= 8.0 Hz, H-11), 7.85
(1H, d, J= 8.0 Hz, H-10), 8.08 (1H, d, J= 8.0 Hz, H-6),
12.98 (1H total, 2 · s, OH) ppm. dC(125 MHz, CDCl3):
6.33 (Si(CH2)2Ph), 6.25 (Si(CH3)2Ph), 18.18 (50-CH3),
18.28 (C3), 19.36 (3-CH3), 24.83 (C1), 29.54 (C2), 39.19 (C4),
39.53 (C2
0), 71.26 (C10), 73.24 (C30), 75.96 (C50), 78.16 (C40),
115.05 (C7a), 119.32 (C11), 124.70 (C6), 127.66 (C2
00, C600),
129.12 (C4
00), 130.86 (C12a), 132.85 (C6a), 133.26 (C10), 133.94
(C11a), 134.59 (C3
00, C500), 135.34 (C5), 135.38 (C9), 136.65
(C1
00), 141.39 (C12b), 145.71 (C4a), 158.01 (C8), 184.89 (C12),
189.32 (C7) ppm.
2.1.4. Synthesis of (3R) and (3S)-3-(dimethylﬂuorolsilanyl)-9-
[20,60-dideoxy-b-D-arabino-hexopyranosyl]-8-hydroxy-3-
methyl-1,2,3,4-tetrahydrobenz[a]anthracene-7,12-dione (22a
and 22b)
A1:1mixture of 21a and 21b (88 mg, 0.200 mmol) andBF3ÆEt2O
(17.6 mL, 0.100 mmol) was stirred at 20 C under nitrogen for
5 h in dichloromethane (35 mL). The mixture was then poured
onto water (100 mL) and extracted into dichloromethane
(2 · 50 mL). The organic layer was then washed with 1 M HCl
(100 mL) water. The organic layer was separated and dried over
anhydrous magnesium sulphate. The solvent was then removed
and the residue puriﬁed by silica gel column chromatography
[methanol/dichloromethane (1:5) as an eluant, RF = 0.37] to
afford a 1:1 mixture of 22a and 22b (77 mg, 89%) as a yellow
solid. LRMS-ESI (): Found m/z 497 [(M–H), 100%].
C27H31FO6Si requires m/z (497) (M–H)
. mmax (KBr): 3426he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
A stereoselective approach to the angucyclinone antibiotics 5(OH), 2923, 1665, 1630, 1581, 1563, 1433, 1368, 1270 cm1.
Found: C, 64.29; H, 6.25%. C27H31FO6Si requires C, 65.04;
H, 6.27%. dH(500 MHz, CDCl3): 0.21 (3H, d, JH–F = 7.5 Hz,
Si((CH3)2F), 0.25 (3H, d, JH–F = 7.5 Hz, Si(CH3)2F), 1.03
(3H, s, 3-CH3), 1.43 (3H, d, J= 6.0 Hz, 5
0-CH3), 1.50 (1H, q,
J = 11.5 Hz, H-20ax), 1.67–1.94 (2H, m, H-2), 2.52 (1H, ddd,
J= 13.0, 5.0, 2.0 Hz, H-20eq), 2.62 (1H, d, J= 17.0 Hz, H-4),
3.11 (1H, d, J= 17.0 Hz, H-4), 3.22 (1H, ddd, J= 9.0, 9.0,
4.0 Hz, H-40), 3.39–3.47 (2H, m, H-1), 3.54 (1H, dq, J= 9.0,
6.0 Hz, H-50), 3.00–3.92 (1H, m, H-30), 4.94 (1H, dd, J= 11.5,
1.5 Hz, H-10), 7.49 (1H, d, J= 8.0 Hz, H-5), 7.76 (1H, d,
J= 8.0 Hz, H-11), 7.88 (1H, d, J = 8.0 Hz, H-10), 8.17 (1H,
d, J= 8.0 Hz, H-6), 12.95 (1H total, 2 · s, OH) ppm.
dC(125 MHz, CDCl3): 4.53 (d, JC–F = 14.5 Hz, Si(CH3)2F),
4.26 (d, JC–F = 14.5 Hz, Si(CH3)2F), 18.19 (50-CH3), 19.21
(3-CH3), 19.78 (C3), 22.73 (C1), 28.24 (C2), 38.33 (C4), 39.53
(C2
0), 71.28 (C10), 73.25 (C30), 75.97 (C50), 78.17 (C40), 115.05
(C7a), 119.4 (C11), 124.9 (C6), 130.97 (C12a), 133.03 (C6a),
133.34 (C10), 133.88 (C11a), 135.25 (C5), 136.21 (C9), 141.11
(C12b), 144.94 (C4a), 158.06 (C8), 184.93 (C12), 189.22 (C7) ppm.
2.1.5. Synthesis of (3R) and (3S)-9-[20,60-dideoxy-b-D-
arabino-hexopyranosyl]-3,8-dihydroxy-3-methyl-1,2,3,4,-
tetrahydrobenz[a]anthracene-7,12-dione (23a and 23b)
A 1:1 mixture of 22a and 22b (33 mg, 66 mmol) in methanol
(5 mL) and tetrahydrofuran (5 mL) was treated with KF
(12.0 mg, 0.200 mmol), KHCO3 (20 mg, 0.20 mmol), and
30% H2O2 (62 lL, 0.60 mmol) under ice. The solution was
then stirred for 20 h at 25 C. The mixture was quenched with
ice cold 10% aqueous Na2S2O3 (9 mL) and extracted into ethyl
acetate (2 · 50 mL). The organic layer was washed with aque-
ous NaCl (200 mL), dried over sodium sulphate and evapo-
rated to dryness. The crude product was puriﬁed by silica gel
column chromatography [hexane/acetone (3:1) as eluant,
RF = 0.14 and RF = 0.18] to afford 1:1 mixture of 23a and
23b (12 mg, 58%) as yellow crystals. HRMS-ESI (): Found
m/z 437.1601 [(M–H), 100%]. C25H25O7 requires m/z
(437.1600) (M–H). mmax (KBr): 3431 (OH), 2926, 1630,
1578, 1271, 1092 cm1. Found: C, 68.27; H, 5.76%.
C25H26O7 requires C, 68.48; H, 5.98%. dH(500 MHz,
CDCl3): 1.41 (3H, s, 3-CH3), 1.42 (3H, d, J= 6.0 Hz, 5
0-
CH3), 1.52 (1H, q, J= 12.0 Hz, H-2
0ax), 1.85–2.01 (2H, m,
H-2), 2.17–2.30 (2H, m, H-1), 2.50 (1H, ddd, J= 13.0, 5.0,
2.0 Hz, H-20eq), 3.00 (2H, s, H-4), 3.22 (1H, t, J = 9.2 Hz,
H-40), 3.49–3.57 (3H, m, H-50), 3.83–3.88 (1H, m, H-30), 4.94
(1H, dd, J= 11.5, 2.0 Hz, H-10), 7.47 (1H, d, J= 8.0 Hz, H-
5), 7.77 (1H, d, J= 8.0 Hz, H-11), 7.89 (1H, d, J= 8.0 Hz,
H-10), 8.18 (1H, d, J = 8.0 Hz, H-6), 12.93 (1H, s, OH)
ppm. dC(125 MHz, CDCl3): 18.19 (50-CH3), 26.63 (C1), 28.86
(3-CH3), 35.83 (C2), 39.52 (C2
0), 45.02 (C4), 68.05 (C3), 71.27
(C1
0), 73.24 (C30), 76.81 (C50), 77.33 (C40), 115.04 (C7a),
119.47 (C11), 125.23 (C6), 131.25 (C12a), 133.28 (C6a), 133.89
(C11a), 135.20 (C5), 136.28 (C9), 140.17 (C12b), 144.42 (C4a),
158.08 (C8), 184.82 (C12), 189.17 (C7) ppm.
2.1.6. Synthesis of (3R) and (3S)-9-[20,60-dideoxy-b-D-
arabino-hexopyranosyl]-3,8-dihydroxy-3-methyl-1,2,3,4-
tetrahydrobenz[a]anthracene-1,7,12-trione; (urdamycinone B
(1) and C-3 epimer urdamycinone B (24)
A 1:1 mixture of 23a and 23b (23 mg, 52.0 mol) from the pre-
vious reaction in MeOH (5 mL) was irradiated with light fromPlease cite this article in press as: Osman, H. et al., A stereoselective approach to t
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atmosphere of oxygen for two days. The residue was puriﬁed
by reverse phase HPLC, 250–10 mm C18 Merck LiChrocart
column, methanol/water (3:1) as eluant, ﬂow rate
1.5 mL min1, detection at 254 nm to give urdamycinone B
(1) (7 mg, 30%, Rt = 14.22 min) and its C-3 epimer urdamyci-
none B (24) (4 mg, 17%, Rt = 18.38 min] as pale yellow solids.
Data for (3R)-9-[20,60-dideoxy-b-D-arabino-hexopyranosyl]-
3,8-dihydroxy-3-methyl-1,2,3,4-tetrahydrobenz[a]anthracene-
1,7,12-trione (1); urdamycinone B. HRMS-ESI (+): Foundm/z
453.1545 (MH+,100%). C25H24O8H requires m/z 453.1549.
mmax (KBr): 3699, 2929, 1604, 1271, 1072 cm
1. [a]D =+52 (c
0.06, MeOH); [lit.26 [a]D =+50 (c 0.012, MeOH).
dH(500 MHz, d-acetone {2.05 ppm}): 1.35 (3H, d, J= 6.5 Hz,
50-CH3), 1.40 (1H, ddd, J= 12.5, 11.5, 11.5 Hz, H-20ax), 1.48
(3H, s, 3-CH3), 2.44 (1H, ddd, J= 12.5, 5.0, 2.0 Hz, H-2
0eq),
2.89 (1H, dd, J= 14.0, 2.0 Hz, H-2 eq), 3.07 (1H, d,
J= 14.0 Hz, H-2ax), 3.26 (1H, dd, J= 9.0, 9.0 Hz, H-40),
3.36 (1H, dd, J= 17.0, 2.0 Hz, H-4 eq), 3.48 (1H, d,
J= 17.0 Hz, H-4ax), 3.73 (1H, m, H-50), 4.14 (1H, dd,
J = 9.0, 9.0 Hz, H-30), 4.89 (1H, dd, J = 11.0, 2.0 Hz, H-10),
7.60 (1H, d, J= 8.0 Hz, H-11), 7.73 (1H, d, J= 8.0 Hz, H-5),
7.93 (1H, dd, J= 8.0, 1.0 Hz, H-10), 8.29 (1H, d, J= 8.0 Hz,
H-6), 12.74 (1H, s, OH) ppm. dC(125 MHz, d-Acetone
{30 ppm}): 18.69 (50-CH3), 40.92 (3-CH3), 44.75 (C20), 54.17
(C4), 71.96 (C2), 72.60 (C1
0), 73.50 (C3), 77.21 (C30), 78.77
(C5
0), 79.13 (C40), 115.89 (C7a), 119.44 (C11), 129.46 (C6),
134.17 (C6a), 134.40 (C10), 134.8 (C5), 135.13 (C11a), 137.10
(C12a, C12b), 138.09 (C9), 150.10 (C4a), 158.89 (C8), 183.43
(C12), 189.12 (C7), 196.84 (C1) ppm.
Data for (3S)-9-[20,60-dideoxy-b-D-arabino-hexopyranosyl]-
3,8-dihydroxy-3-methyl-1,2,3,4-tetrahydrobenz[a]anthracene-
1,7,12-trione (24); C-3 epi-urdamycinone B. HRMS-ESI (+):
Found m/z 453.1551 (MH+, 100%). C25H24O8H requires m/
z 453.1549. mmax (KBr): 3680 (OH), 2930, 1605, 1271,
1073 cm1. [a]D =+156 (c 0.132, CHCl3); [lit.
26
[a]D =+150 (c 0.023, CHCl3)]. dH(500 MHz, d-Acetone
{2.05 ppm}): 1.35 (3H, d, J= 6.5 Hz, 50-CH3), 1.40 (1H,
ddd, J = 12.5, 11.5, 11.5 Hz, H-20ax), 1.48 (3H, s, 3-CH3),
2.44 (1H, ddd, J= 12.5, 5.0, 2.0 Hz, H-20eq), 2.89 (1H, dd,
J= 14.0, 2.0 Hz, H-2 eq), 3.07 (1H, d, J= 14.0 Hz, H-2ax),
3.26 (1H, dd, J= 9.0, 9.0 Hz, H-40), 3.36 (1H, dd, J= 17.0,
2.0 Hz, H-4 eq), 3.48 (1H, d, J= 17.0 Hz, H-4ax), 3.73 (1H,
m, H-50), 4.13 (1H, dd, J= 9.0, 9.0 Hz, H-30), 4.91 (1H, dd,
J= 11.0, 2.0 Hz, H-10), 7.60 (1H, d, J= 8.0 Hz, H-11), 7.73
(1H, d, J= 8.0 Hz, H-5), 7.93 (1H, dd, J= 8.0, 1.0 Hz, H-
10), 8.30 (1H, d, J= 8.0 Hz, H-6), 12.74 (1H, s, OH) ppm.
dC(125 MHz, d-Acetone {29.20 ppm}): 18.05 (50-CH3), 40.25
(3-CH3), 44.11 (C2
0), 53.53 (C4), 71.33 (C2), 71.92 (C10), 72.86
(C3), 76.56 (C3
0), 78.11 (C50), 78.44 (C40), 115.25 (C7a), 118.79
(C11), 128.81 (C6), 133.53 (C6a), 133.76 (C10), 134.19 (C5),
134.47 (C11a), 136.48 (C12a, C12b), 137.46 (C9), 149.44 (C4a),
158.27 (C8), 182.80 (C12), 188.49 (C7), 196.20 (C1) ppm.2.2. Asymmetric synthesis of urdamycinone B (Chiral Lewis
acid promoted diels–alder reaction)
2.2.1. Preparation of borane–tetrahydrofuran complex
Borane-tetrahydrofuran complex was prepared using the
method described by Brown (1975) and Vogel et al. (1978).he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
6 H. Osman et al.2.2.2. Procedure for the synthesis of 3-(dimethylphenylsilanyl)-
9-[30,40-di-O-acetyl-20,60-dideoxy-b-D-arabino-hexopyranosyl]-
8-hydroxy-3-methyl-6-trimethylsilanyloxy-1,2,3,4,6,6a,12a,12b-
octahydrobenz[a]anthracene-7,12-dione (19a–d)
Borane–tetrahydrofuran (1.20 mL. 1.32 M, 1.58 mmol) was
added to a stirred solution of (S)-3,30-diphenyl-1,10-binaph-
thalene-2,20-diol (458 mg, 1.07 mmol) in THF at 0 C under
argon atmosphere. Acetic acid (101.5 lL, 1.78 mmol) was then
added. The cooling bath was removed and the mixture was stir-
red until 25 min. The solvents were removed on a vacuum to
give a creamy white residue. Dienophile (17) (229 mg,
0.59 mmol) in dry dichloromethane (5 mL) was added which
resulted in the formation of a deep red solution. The mixture
was stirred for 1 min at room temperature and then cooled to
78 C. It was then added, via an oven dried cannula jacketed
with dry ice, to a solution of (±) siloxydiene (13) (454 mg,
1.36 mmol) in dichloromethane at 78 C. After the addition
was completed it was stirred for a further 10 min at the same
temperature. It was poured onto a solution of saturated aque-
ous sodium chloride (100 mL). The mixture was extracted with
dichloromethane (2 · 100 mL) washed with water. The organic
layer was separated and dried over anhydrous magnesium sul-
phate. The solvent was evaporated to dryness and puriﬁcation
by silica gel column chromatography [hexane/diethyl ether
(2:1) as eluant, RF = 0.44] afforded a 9:1 mixture of 19a–d
(328 mg, 76%) as a yellow solid. All the data were consistent
with that for a 1:1 mixture of 19a–d described previously.Scheme 3 The stereoselective synthesis of 19
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(dimethylphenylsilanyl)-9-[30,40-di-O-acetyl-20,60-dideoxy-b-D-
arabino-hexopyranosyl]-8-hydroxy-3-methyl-1,2,3,4-
tetrahydrobenz[a]anthracene-7,12-dione (20a and 20b)
Using the procedure described for the synthesis 20a and 20b, a
mixture 9:1 of 19a–d (200 mg, 0.30 mmol) from the previous
reaction and DBU (302 lL, 2.0 mmol) in dry dichloromethane
(10 mL) was stirred at room temperature for 30 min under an
atmosphere of air gave, after puriﬁcation by silica gel column
chromatography [hexane/diethyl ether (2:1) as eluant,
RF = 0.18] to afford a 4:1 mixture of 20a and 20b (148 mg,
85%) as a yellow solid. HRMS-ESI (+): Found m/z 641.2573
(MH+, 100%). C37H40O8SiH requires m/z 641.2571. All the
data were consistent with that for a 1:1 mixture of 20a and 20b
described previously.
2.2.4. Procedure for the synthesis of (3R) and (3S)-3-
(dimethylphenylsilanyl)-9-[20,60-dideoxy-b-D-arabino-
hexopyranosyl]-8-hydroxy-3-methyl-1,2,3,4-
tetrahydrobenz[a]anthracene-7,12-dione (21a and 21b)
Using the procedure described for the synthesis 21a and 21b, a
solution of a 4:1 mixture of 20a and 20b (580 mg, 0.90 mmol) in
THF (40 mL) was added to a cooled solution of sodiummethox-
ide (489 mg, 9.1 mmol) in methanol (60 mL) at 0 C gave, after
puriﬁcation a 4:1 diastereomeric mixture of 21a and 21b [hex-
ane/acetone (5:2) as eluant,RF = 0.29] (490 mg, 98%)as a yellow
solid. HRMS-ESI (+): Found m/z 557.2360 (MH+, 100%).from C-glycosyl juglone 17 and diene 13.
he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
Figure 1 Dienophile complex 18.
A stereoselective approach to the angucyclinone antibiotics 7C33H36O6SiH requiresm/z 557.2359. All the data were consistent
with that for a 1:1 mixture of 21a and 21b described previously.
2.2.5. Procedure for the synthesis of (3R) and (3S)-3-
(dimethylﬂuorosilanyl)-9-[20,60-dideoxy-b-D-arabino-
hexopyranosyl]-8-hydroxy-3-methyl-1,2,3,4-
tetrahydrobenz[a]anthracene-7,12-dione (22a and 22b)
Using the procedure described for the synthesis 22a and 22b, a
4:1 mixture of 21a and 21b (460 mg, 0.80 mmol) and BF3.Et2O
(92 mL) was stirred at 20 C under nitrogen for 5 h in dichlor-
omethane (184 mL) gave, after puriﬁcation by silica gel col-
umn chromatography [hexane/acetone (3:2), RF = 0.20] to
afford the 4:1 diastereomeric mixture of 22a and 22b
(382 mg, 93%) as a yellow solid. HRMS-ESI (+): Found m/
z 499.1955 (MH+, 100%). C27H31FO6SiH requires m/z
499.1952. All the data were consistent with that for a 1:1 mix-
ture of 22a and 22b described previously.2.2.6. Procedure for the synthesis of (3R) and (3S)-9-[20,60-
dideoxy-b-D-arabino-hexopyranosyl]-3,8-dihydroxy-3-methyl-
1,2,3,4-tetrahydrobenz[a]anthracene-7,12-dione (23a and 23b)
Using the procedure described for the synthesis 23a and 23b,
potassium ﬂuoride (KF) (49.8 mg, 0.90 mmol), potassium
hydrogen carbonate (KHCO3) (85 mg, 0.90 mmol), and 30%
hydrogen peroxide (H2O2) (80.0 lL, 2.6 mmol) were added
to a 4:1 mixture of 22a and 22b (142 mg, 0.30 mol) from the
previous reaction in methanol (10 mL) and tetrahydrofuran
(10 mL) at 0 C, gave after puriﬁcation by silica gel column
chromatography [hexane/acetone (3:1) as eluant, RF = 0.14
and RF = 0.18] to afford 23a and 23b (90 mg, 72%) as a 4:1
yellow crystalline mixture of diastereoisomers. HRMS-ESI
(+): Found m/z 439.1760 (MH+, 100%). C25H26O7H requires
m/z 439.1757. All the data were consistent with that for a 1:1
mixture of 23a and 23b described previously.Please cite this article in press as: Osman, H. et al., A stereoselective approach to t
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dideoxy-b-D-arabino-hexopyranosyl]-3,8-dihydroxy-3-methyl-
1,2,3,4-tetrahydrobenz[a]anthracene-1,7,12-trione;
(urdamycinone B (1) and C-3 epimer urdamycinone B (24)
Using the procedure described for the synthesis 23a and 23b, a
4:1 mixture of 23a and 23b (60 mg, 0.14 mmol) from the previ-
ous reaction in MeOH (mL) was irradiated with light from a
160 W broad-spectrum tungsten ﬁlament lamp under an atmo-
sphere of oxygen for one day. The solution was concentrated
in vacuo. The residue was puriﬁed by reverse phase HPLC,
250–10 mm C18 Merck LiChrocart column, methanol/water
(3:1) as eluant, ﬂow rate 1.5 mL min1, detection at 254 nm
to give urdamycinone B (1) (31 mg, 50%, Rt = 13.12 min)
and its C-3 epimer urdamycinone B (24) (8 mg, 13%,
Rt = 16.62 min) as pale yellow solids. All the data were con-
sistent with that for a 1:1 mixture of 1 and 24 described
previously.3. Results and discussion
We began the synthesis of C-glycoside (17) by Friedel–Crafts
C-glycosylation as reported by Andrews and Larsen in the ﬁrst
syntheses of C-glycosyl-juglone derivatives. C-glycoside (17)
was successfully synthesised by hydrolysis from 16, which
was synthesised from a sequence reactions in 75% yield. The
structure of C-glycoside (17) was conﬁrmed by spectral data
and consistent with our earlier report (Andrews et al., 2000;
Osman et al., 2008, 2009).
The cycloaddition of C-glycoside 17 and diene 13 was stud-
ied using three different sets of reaction conditions (Scheme 3).
The thermal Diels–Alder reaction (reaction conditions A) of 17
and diene 13 gave cycloadducts 19a–d in 51% yield as aninseparable mixture. Cycloadduct 19 analysed correctly for
C40H52O9Si2. Although the
1H NMR spectrum of 19 was com-
plex, most of the resonances for each isomer were coincident.
The vinyl proton for each isomer, H-5, resonated at d
5.49 ppm as a one-proton double triplet with coupling con-
stants, J= 5.0 and 2.5 Hz, while H-6 resonated at d
4.42 ppm as a triplet with a coupling constant, J= 4.5 Hz.
Two three-proton singlets at d 2.01 and 2.08 ppm were attrib-
uted to the acetate methyl groups of the sugar residue. A three-
proton doublet at d 1.29 ppm was assigned to the C-50 methyl
group. The C-3 methyl protons resonated as a three-proton
singlet at d 0.85 ppm and two three-proton singlets at d 0.42
and 0.46 ppm were due to the methyl substituent of the
phenyldimethylsilyl group. Four three-proton singlets between
d 0.24 and 0.30 ppm were attributed to the trimethylsilyl
group of each cycloadduct.he angucyclinone antibiotics: A total synthesis of (±)-urdamycinone B. Arabian
Figure 2 1H NMR spectra of the phenolic region of cycloadducts 19a–d prepared from the compounds of 17 and 13 using reaction
conditions A, B and C.
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Figure 3 Lowest energy transition state of the reaction between
diene (±)-(13) and dienophile complex 18.
A stereoselective approach to the angucyclinone antibiotics 9The tetra-O-acetyldiborate promoted reaction (reaction
conditions B) gave 19a–d in 88% yield. Similarly, reaction con-
ditions C, which involved complex 18 (Fig. 1) as the reactive
dienophile, gave 19a–d in 76% yield.
The phenolic protons of cycloadducts 19a–d resonated at d
12.50, 12.49, 12.40 and 12.39 ppm. The structures of the
diastereomeric pairs 19a and d & 19b and c were assigned on
the basis of the facial selectivity of diene 13 which was reported
by Landells in his synthesis of tetrangomycin (7) (Landells
et al., 2003). The more predominant pair, 19a and d, is formed
by addition of the dienophile to the less hindered face of each
enantiomer of 13 which syn to the large dimethylphenylsilyl
group. The structure of 19a was also assigned by analogy to
the work of Landells. Applying his model of facial selectivity
of chiral dienophile complex 9 to the dienophile complex 18
used in the current study, the predominant product from reac-
tion of 18 and diene (±)-13 would be 19a (Fig. 2).
The structures of the predominant cycloadducts 19a and
19d were tentatively assigned on the basis that they arise from
reaction of the dienophile with the more reactive face of theFigure 4 The integration of the phenolic proton signals of aroma
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Cycloadduct 19a is formed by reaction of (S)-13 reacting from
the bottom face of the dienophile as depicted in Fig. 3.
Similarly, 19d arises from reaction of (R)-13 with the top
face of the dienophile. Conversely, the minor cycloadducts
19b and 19c arise from the reaction of the dienophile with
the less reactive face, anti to the phenyldimethylsilyl group,
of each enantiomer of diene 13. Cycloadducts 19b and 19c
are formed via the endo-transition states.
The ratio of the signals within each pair of cycloadduct
reﬂects the facial selectivity of the dienophile component.
For the thermal Diels–Alder reaction the ratio of 19a–d was
approximately 1.4:1. This suggests that under these reaction
conditions the bottom-face of dienophile 17, is slightly more
reactive than the top face. Presumably the C-glycosyl residue
is the cause of this. On the basis of this argument, cycloadduct
19b, which arises by reaction of (R)-13 with the bottom face of
17, should be formed in preference to 19c. Consequently, the
phenolic signal at d 12.39 ppm was assigned to 19b and the sig-
nal at d 12.40 ppm to 19c (Fig. 2).
When tetra-O-acetyldiborate was used to promote the
Diels–Alder reaction the ratio of adducts within each pair
was 1:1. Clearly the sugar residue has no effect on the facial
selectivity of the corresponding Lewis acid complex of 17.
The phenolic region of the 1H NMR spectrum of the Diels–
Alder cycloaddition product carried out using reaction condi-
tions C indicated good asymmetric induction. The ratio of 19a
to 19d was approximately 14:1 while that of 19b–c was 4:1.
These ratios suggest that the endo-transition state is favoured.
The ratio of the cycloadducts, from the chiral Lewis acid
promoted reaction (reaction conditions C) was signiﬁcantlytisation product 20, produced from the asymmetric synthesis.
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10 H. Osman et al.different to those obtained from the integration of the phenolic
signals. The major difference was the ratio of 19a–d, which was
found to be 4:1 from the trimethylsilyl signals versus 14:1 from
the phenolic signals. This difference was ascribed to the inaccu-
racy of integration. On this basis, the ratio of 19a–d was
believed to lie between these two values.
Aromatisation of the mixtures 19a–d gave 20 in 85% yield.
In this case the ratio of 20a:20b was approximately 4:1 based
upon integration of the resonances of the phenolic protons
(Fig. 4). Diastereoisomer 20a should be formed from adducts
19a and 19c. Similarly 20b is derived from 19b and 19d. Due
to preferential formation of adduct 19a in the Diels–Alder
reaction tetracycle 20a should be formed in excess. Thus, the
ratio of 20a and 20b will determine the diastereoisomeric
excess of urdamycinone B (1) to that of C-3 epi-urdamycinone
B (24) (Scheme 4). Four one-proton doublets at d 7.41 (H-5),
7.73 (H-11), 7.84 (H-10) and 8.09 (H-6) ppm were attributed
to the aromatic protons of the benz[a]anthraquinone nucleus
and conﬁrmed that the aromatisation of the B-ring had
occurred. The lack of any signals close to d 0.00 ppm con-
ﬁrmed the loss of the trimethylsilyl group.
Deacetylation of the mixture of 20a and 20b will give a
mixture of 21a and 21b in 98% yield. At this stage the syn-
thesis will converge with that of Matsuo et al. (1996, 1999).
Their methodology will be used to access urdamycinone B
(1).
The next step involved the treatment of 21a and 21b with
boron triﬂuoride etherate afforded 22a and 22b (89%). TheScheme 4 The synthesis o
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correlated well with those previously reported by Matsuo et al.
The lack of resonances due to the phenyl group in the 1H
NMR spectrum also conﬁrmed the formation of 22. The dia-
stereotopic methyl groups vicinal to the ﬂuorine atom
appeared as two doublets at d 0.24 and 0.25 ppm, with cou-
pling constants of 3JH,F = 7.5 Hz in the
1H NMR spectrum.
These methyl groups resonated as doublets at d 4.53 and
4.26 ppm (2JC,F = 14.5 Hz) in the 13C NMR spectrum.
Subsequent oxidation with hydrogen peroxide and potas-
sium ﬂuoride, in a mixture of methanol and THF gave tertiary
alcohols 23a and 23b in 58% yield. Oxidation of 23 under an
oxygen atmosphere was achieved by irradiation with light from
a tungsten ﬁlament lamp to give urdamycinone B (1) and its C-3
epimer 24 (Scheme 4). The 1:1 mixture of 23a and 23b, originat-
ing from the tetra-O-acetyldiborate promoted Diels–Alder
strategy, gave a 1:1 mixture of 1 and its C-3 epimer 24 in
68% yield. The 4:1 mixture of 23a and 23b, from the asymmet-
ric synthesis, afforded 1 and 24 in 79% yield. These compounds
could not be separated by silica gel column chromatography.
Matsuo et al. separated 1 and 24 by preparative reverse
phase thin layer chromatography. They found that the faster
moving isomer was urdamycinone B (1). This was conﬁrmed
by comparison of the NMR spectra and optical rotation with
those of an authentic sample of the natural product. In the cur-
rent work, separation was achieved by semi-preparative
reverse phase high performance liquid chromatography
(HPLC). Approximately the 1:1 mixture of 1 and 24 gave 1f urdamycinone B (1).
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Figure 5 Separation of urdamycinone B (1) and C-3 epimer (24) by reverse phase HPLC (250–10 mm C18 Merck LiChrocart column,
eluant 3:1 MeOH and H2O, 1.5 mL min
1, detection at 254 nm).
A stereoselective approach to the angucyclinone antibiotics 11in 30% yield and 24 in 17% yield while the material prepared
from the asymmetric Diels–Alder strategy gave 1 in 50% yield
and 24 in 13% yield. The chromatogram for the latter separa-
tion is shown in Fig. 5 and the peak areas conﬁrm the ratio of 1
and 24 as 4:1.
The structure of 1 was conﬁrmed from its spectral data. A
peak at m/z 453.1545 in the positive ion ESI high resolution
mass spectrum was attributed to (MH)+ and conﬁrmed the
molecular formula as C25H24O8. The speciﬁc rotation,
[a]D =+52 (c 0.06, MeOH), was consistent with that reported
by Matsuo et al. [a]D =+50 (c 0.012, MeOH). The
1H NMR
spectrum of 1 is also consistent with that reported by Matsuo
et al. C-3-epi-Urdamycinone B (24) showed a peak at m/z
453.1551 in the high resolution ESI mass spectrum. This was
attributed to (MH)+ and conﬁrmed the molecular formula
as C25H24O8. Once again all spectral data were consistent with
those reported in the literature (Matsuo et al., 1996, 1999;
Yamaguchi et al., 1992). The speciﬁc rotation, [a]D =+156
(c 0.132, CHCl3) was similar to that reported by Matsuo
et al., [a]D =+150 (c 0.023, CHCl3) (Matsuo et al., 1999).
The structure of 1 has been unambiguously established by
chemical synthesis (Larsen and O’Shea, 1993a; Rozek et al.,
1998). Given that 1 possesses the 3-R conﬁguration, the major
stereoisomer of the intermediates 20, 21, 22 and 23 must pos-
sess the 3-S conﬁguration. The stereochemical outcome of the
synthesis supports the proposed model for the asymmetric
induction in the Diels–Alder reaction shown in Scheme 3,
where the lowest energy approach of the diene 13 and dieno-
phile complex 18 is as depicted in Fig. 3.4. Conclusion
In summary, we have presented facial selectivity of the diene
13 with C-glycosyl juglone 17, via complex 9 to the synthetic
route of the synthesis of Urdamycinone B and its epimer.
Interestingly both diastereomers have been successfully sepa-
rated by HPLC method.Please cite this article in press as: Osman, H. et al., A stereoselective approach to t
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